GSA Capital Partners’s CureVac CVAC Stock Holding History

GSA Capital Partners’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,744	Closed	-$49K	–	1807
2025 Q4	$49K	Buy	+10,744	New	+$55K	﹤0.01%	1573
2025 Q2	–	Sell	-307,941	Closed	-$853K	–	1805
2025 Q1	$853K	Buy	+307,941	New	+$1.07M	0.08%	443
2024 Q2	–	Sell	-10,335	Closed	-$31K	–	1689
2024 Q1	$31K	Buy	+10,335	New	+$36.3K	﹤0.01%	1544

GSA Capital Partners's CVAC Position: Q1 2026 in Review

GSA Capital Partners sold out of CureVac (CVAC) in Q1 2026, closing a stake of 10,744 shares — an estimated $49K sold.

GSA Capital Partners first reported a position in CVAC in Q1 2024 and held it in 3 quarters. The position peaked at $853K in Q1 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

GSA Capital Partners reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
GSA Capital Partners sold 10,744 CureVac shares in Q1 2026, an estimated $49K.
GSA Capital Partners first reported a position in CureVac in Q1 2024 and held it in 3 quarters.
GSA Capital Partners's CureVac position peaked at $853K in Q1 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.